PORTSDOWN GROUP PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: J82155 | PORTSMOUTH, PO2 8AL
Showing results 451-500 of 936
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Oral rehydration salts | 140 | 3,552 | £1.2K | +384.6% ▲ |
| Alogliptin | 139 | 6,279 | £5.7K | -45.2% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 139 | 2,980 | £225 | +825.1% ▲ |
| Fosfomycin trometamol | 138 | 177 | £819 | +384.9% ▲ |
| Powder preterm infant formula (0913111) | 138 | 407.2K | £6.6K | +766.6% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 138 | 223.6K | £10.0K | +419.5% ▲ |
| Azelaic acid | 138 | 4,410 | £731 | +477.3% ▲ |
| Terbinafine hydrochloride | 137 | 3,810 | £696 | +269.2% ▲ |
| Buspirone hydrochloride | 136 | 5,851 | £1.3K | +169.9% ▲ |
| Trihexyphenidyl hydrochloride | 136 | 14.7K | £5.7K | +379.6% ▲ |
| Glycopyrronium bromide | 134 | 5,910 | £5.1K | +259.5% ▲ |
| Levomepromazine hydrochloride | 133 | 1,198 | £2.3K | +477.7% ▲ |
| 132 | 1,766 | £7.4K | +1,434.7% ▲ | |
| 132 | 399 | £1.6K | +325.6% ▲ | |
| 131 | 5,100 | £21.4K | +189.7% ▲ | |
| Potassium chloride | 130 | 13.7K | £1.3K | +595.4% ▲ |
| Acetazolamide | 130 | 14.0K | £541 | +500.0% ▲ |
| Amiloride hydrochloride | 129 | 5,159 | £2.5K | +412.5% ▲ |
| Moxonidine | 129 | 8,540 | £1.3K | +131.7% ▲ |
| Potassium permanganate | 129 | 2,658 | £2.5K | +4,880.8% ▲ |
| Duloxetine hydrochloride | 128 | 8,239 | £1.5K | +149.8% ▲ |
| Menthol | 128 | 51.2K | £1.9K | +354.5% ▲ |
| Hyoscine hydrobromide | 127 | 8,052 | £1.3K | +271.9% ▲ |
| Light liquid paraffin | 127 | 55.5K | £1.3K | +273.1% ▲ |
| Chlorpromazine hydrochloride | 126 | 8,643 | £7.1K | +220.4% ▲ |
| Dexamfetamine sulfate | 126 | 16.4K | £17.5K | +250.5% ▲ |
| 125 | 1,619 | £4.3K | +816.5% ▲ | |
| 123 | 6,145 | £1.2K | +52.9% ▲ | |
| Imipramine hydrochloride | 122 | 3,304 | £136 | +378.6% ▲ |
| Lofepramine hydrochloride | 121 | 4,949 | £2.1K | +304.5% ▲ |
| Goserelin acetate | 121 | 121 | £11.9K | +174.7% ▲ |
| Ofloxacin | 120 | 3,192 | £3.4K | +1,360.4% ▲ |
| Norethisterone | 120 | 12.8K | £312 | +758.1% ▲ |
| Betamethasone esters | 119 | 8,340 | £877 | +97.2% ▲ |
| Ferrous gluconate | 118 | 7,112 | £201 | +146.7% ▲ |
| 118 | 15.7K | £3.2K | +332.2% ▲ | |
| Exemestane | 117 | 2,924 | £552 | +260.1% ▲ |
| 117 | 7,450 | £5.0K | +744.4% ▲ | |
| Bimatoprost | 116 | 2,616 | £1.6K | -22.0% ▼ |
| 115 | 8,166 | £15.6K | +188.3% ▲ | |
| Etoricoxib | 114 | 4,256 | £813 | +41.5% ▲ |
| Glycopyrronium bromide | 113 | 16.0K | £15.0K | +450.4% ▲ |
| 113 | 1,604 | £8.5K | +306.1% ▲ | |
| Bicalutamide | 112 | 4,088 | £275 | +246.2% ▲ |
| 112 | 1,502 | £3.5K | +429.8% ▲ | |
| 112 | 6,870 | £344 | +106.3% ▲ | |
| Valsartan | 110 | 6,944 | £1.5K | +86.8% ▲ |
| 109 | 8,590 | £1.1K | +965.7% ▲ | |
| Nizatidine | 107 | 3,510 | £1.7K | +211.0% ▲ |
| 106 | 268 | £5.3K | +667.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.